Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
13.86
-0.09 (-0.65%)
At close: Oct 7, 2025, 4:00 PM EDT
13.86
0.00 (0.00%)
After-hours: Oct 7, 2025, 6:30 PM EDT
Medifast Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Medifast stock has a target of 16.5, which predicts a 19.05% increase from the current stock price of 13.86.
Price Target: $16.5 (+19.05%)
Analyst Consensus: Hold
* Price targets were last updated on Feb 19, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Medifast is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Hold Maintains $17 → $17 | Hold | Maintains | $17 → $17 | +19.05% | Feb 19, 2025 |
| DA Davidson | DA Davidson | Sell → Hold Upgrades $17 → $17 | Sell → Hold | Upgrades | $17 → $17 | +22.66% | Nov 5, 2024 |
| DA Davidson | DA Davidson | Sell Maintains $18 | Sell | Maintains | $18 | +26.26% | Jul 22, 2024 |
| DA Davidson | DA Davidson | Hold → Sell Downgrades $25 → $18 | Hold → Sell | Downgrades | $25 → $18 | +26.26% | Jun 5, 2024 |
| DA Davidson | DA Davidson | Hold Maintains $40 → $25 | Hold | Maintains | $40 → $25 | +80.38% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
382.99M
from 602.46M
Decreased by -36.43%
Revenue Next Year
355.62M
from 382.99M
Decreased by -7.15%
EPS This Year
-0.94
from 0.19
EPS Next Year
-1.41
from -0.94
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 398.2M | 369.7M |
| Avg | 383.0M | 355.6M |
| Low | 371.6M | 345.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -33.9% | -3.5% |
| Avg | -36.4% | -7.1% |
| Low | -38.3% | -9.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.98 | -1.47 |
| Avg | -0.94 | -1.41 |
| Low | -0.91 | -1.37 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.